Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.14
Delayed Data
As of 1:48pm ET
 +0.04 / +1.90%
Today’s Change
1.85
Today|||52-Week Range
4.19
-19.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash30.1M81.5M48.5M45.0M
 
 
 
 
 
Short Term Investment Cash-1.2M51.4M-33.0M-2.5M
 
 
 
 
 
Cash & Short Term Investments39.7M100.6M91.5M97.7M
 
 
 
 
 
 
ReceivablesReceivables0.000.00------
 
InventoriesInventories0.000.00------
 
Current AssetsOther Current Assets561.0K786.0K765.0K1.7M
 
 
 
 
 
Current Assets40.3M101.4M92.2M99.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross20.7M21.3M22.0M21.5M
 
 
 
 
 
Depreciation-19.3M-20.1M-20.5M-20.5M
 
 
 
 
 
Other Assets631.0K458.0K1.4M305.0K
 
 
 
 
 
Total Assets42.3M103.0M95.2M100.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.5M5.7M6.6M3.1M
 
 
 
 
 
Short Term Debt4.2M7.9M9.5M9.3M
 
 
 
 
 
Accrued Expenses4.5M6.6M13.0M14.6M
 
 
 
 
 
Other Current Liabilities4.5M6.6M13.0M14.6M
 
 
 
 
 
Other Liabilities15.1M23.5M32.2M30.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt12.4M4.5M13.9M4.7M
 
 
 
 
 
Total Liabilities27.6M28.0M46.1M35.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity14.8M75.1M49.1M65.1M
 
 
 
 
 
Total Shareholder Equity14.8M75.1M49.1M65.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding49.5M68.9M85.2M109.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.